Jensen A, 1992. (Pregnancy length 147 days). Validation of CVP score Validation of CVP score The role of echocardiography in prenatal diagnosis of pulmonary.

Slides:



Advertisements
Similar presentations
CV Profile Scoring and Assessment
Advertisements

Perinatal Health in Canada: An Overview K.S. Joseph MD, PhD Canadian Perinatal Surveillance System.
Farhan Hanif,MD Maternal Fetal Medicine
Anomalies of the PV and RV James C. Huhta, M.D. Perinatal Cardiology JHM-All Children’s Hospital 5th Phoenix Fetal Cardiology Symposium Wed. April 23,
IUGR fetuses IUGR fetuses Erich Cosmi MD Department of Gynecological Science and Human Reproduction Section of Maternal and Fetal Medicine University of.
Ebstein’s anomaly Stephanie Merhar January 21, 2011.
Deborah A. Bruns, Ph.D. Emily Campbell SOFT Conference July 2013 Providence/Warwick, RI.
Perinatal Varicella By Rafat Mosalli MD FAAP FRCPC.
Outcome of diabetic pregnancy Comparison of North East England with Norway December 2000 Gillian Hawthorne.
Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.
بسم الله الرّحمن الرّحیم Hypertension in pregnancy R.Mohammadjafari.MD.Gynecologist.
Intra-uterine Growth Restriction
VITAL STATISTICS AIM : To reduce maternal, fetal and neonatal deaths related to pregnancy and labour by evaluating the data and taking measures to prevent.
ROLE OF FETAL ECHOCARDIOGRAPHY IN CONGENITAL HEART DISEASES BY JAMEEL A. AL-ATA CONSULTANT AND ASSISTANT PROFESSOR OF PEDIATRIC CARDIOLOGY.
Small Babies IUGR and SGA. Small-for-gestational-age A baby whose birth weight or estimated fetal weight is below a specified centile for its gestation.
Ultrasound in Obstetrics and Gynecology
Loop diuretics VS venous ultrafiltration in cardio-renal syndrome Radek Debiec SHO Renal Medicine LGH Sept 2013.
The Role of Ultrasound in Obstetrics and Gynaecology Max Brinsmead MB BS PhD May 2015.
Presented by: Dr. Farzad Afzali Kasra medical imaging center.
Fetal Dopplers- A Review
ASSESSMENT OF FETAL WELLBEING Max Brinsmead MB BS PhD May 2015.
First Trimester Screening
The State of Ohio Universal Prenatal Booking David S. McKenna, MD, RDMS Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH.
Heart Failure Khalid F AlHabib.MBBS.FRCPC Cardiology Consultant King Fahad Cardiac Centre King Saud University Wednesday, September 02, 2015Wednesday,
Predicting Patients at Risk for Poor Global Outcomes after DT- MCS Therapy Suzanne V. Arnold, MD, MHA Saint Luke’s Mid America Heart Institute/UMKC May.
Pulse Oximetry screening for Cardiac malformations in the neonate Majd Abu-Harb September 2014.
First and Early Second Trimester Diagnosis of Fetal Heart Disease 성균관의대 소아과 삼성제일병원 진단방사선과 민 지 연.
CARDIAC DISEASE IN PREGNANCY. Physiologic Changes of Pregnancy Blood volume and cardiac output rise in pregnancy to a peak that is 150% of normal by 24.
Differential Diagnosis. Many classes of disorders can result in increased cardiac demand or impaired cardiac function. Cardiac causes include: - arrhythmias.
In the name of god First Trimester Screening Dr.M.Moradi.
UOG Journal Club: August 2011
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
… could their antioxidant and antiinflammatory components interfere with prostaglandin metabolism and thus influence fetal ductus arteriosus dynamics?
History ♀ ♂ First identified as a cytogenetic syndrome in 1960.
Max Brinsmead MB BS PhD May 2015
TEMPLATE DESIGN © Fetal outcome of prenatally diagnosed congenital abnormality: A Retrospective study” Vallikkannu Narayanan.
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
Fetal Echocardiography Dr. Durr-e-Sabih Una contribucion para Dr Lattus de Dr. Hector Fernandez.
In the name of god.
South Dakota Perinatal Association (SDPA) 40th Annual Conference September 10-11, 2015.
Fetal death in pregnant diabetic women B-Khani Assistant professor of Isfahan University of Medical Science.
C ASE REPORT FOR V. GRADE STUDENTS Cardiology Dr. Kemény Viktória.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
Congenital Heart Disease in South Texas Nadine Aldahhan, D.O.; Cherie Johnson, M.D., FACOG, MMM; Priscilla Gutierrez, RDMS, RDCS, RVT Christus Spohn Family.
Marc G Cribbs, MD Director, Alabama Adult Congenital Heart Program University of Alabama at Birmingham Children’s of Alabama Alabama Adult Congenital Heart.
Telephonic survey of the use of pulse oximetry as part of routine baby checks S Goyal, S Sen.
CoRPS Disclosures None. CoRPS Center of Research on Psychology in Somatic diseases Impact of psychological profile in heart failure patients Susanne S.
DR NOORZADEH fellowship of perinatology Shariati hospital
In the Name of God. All women should be assessed at booking for risk factors for a SGA fetus/neonate to identify those who require increased surveillance.
Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetus G.MARI, F HANIF, M KRUGER, et. al,.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Atrioventricular septal defects diagnosed in fetal.
Natalia Cruces, Marta Sobral, Amália Pacheco, Ivone Lobo Department of Obstetrics and Gynecology Hospital de Faro (Portugal) Amnioinfusion to Treat Severe.
"Fetal Diagnosis and Treatment of Cardiovascular Conditions" Shanthi Sivanandam, MD,FASE Medical Director, Fetal Cardiology Co- Director, Echocardiography.
Heart Failure in Women Dr. Jennifer Haythe
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
UOG Journal Club: August 2017
The cardiovascular system
Tabassum Firoz MD MSc FRCPC University of British Columbia
Dr vera amarin, Dr hazem haboob
Fetal growth restriction
Antepartum Assessment and Care
Prenatal Ultrasound & Early Detection of FASD
Antepartum Assessment and Care
Antepartum Fetal Surveillance
Lithium Use During Pregnancy
Finn Lauszus, Hanne Søndergaard, Carsten Byrialsen, Ervin Kallfa
Rheusus iso-Immunization L2
Aarhus University Hospital, Aarhus, Denmark
Presentation transcript:

Jensen A, (Pregnancy length 147 days)

Validation of CVP score Validation of CVP score The role of echocardiography in prenatal diagnosis of pulmonary arteriovenous malformation Sinkovskaya E, Berkley E, Bogdan D, Sclater A, Abuhamad A The role of echocardiography in prenatal diagnosis of pulmonary arteriovenous malformation Prenatal Diagnosis 2009; 29: CVP score 7/10 Effusion, cardiomegaly (area ratio 0.47), decreased SF 0.27

Digoxin Therapy for the fetus in CHF Structural cardiac defects (n= 21) or noncardiac anomalies (n=7 ) Length of treatment (5.0 ± 3.2 weeks) Patel DPatel D, Cuneo B, Viesca R, Rasanan J, Leshko J, Huhta J. Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score. J Matern Fetal Neonatal Med Jul;21(7):477-82Cuneo BViesca RRasanan JLeshko JHuhta J

Results-Digoxin treatment group Mortality was 32%, and limited to those with moderate (3/13) and severe (6/9) CHF. A CVPS of ≥ 6 was the best predictor of survival (sensitivity 0.83, specificity 0.75). All fetuses that died in utero had notching of the umbilical venous flow. The first, last and CVPS after 1 week of treatment predicted survival (Odds ratio 2.34, 95% CI ).

Results The overall CVPS increased from baseline during treatment (p = 0.003) in all subjects. The CVPS score is useful in assessing therapeutic effects of digoxin in the fetus with multiple etiologies for CHF

Validation of CVP score-Sacrococcygeal Teratoma To determine the value of CVP Score for the prognosis of the fetus with SCT 26 fetuses with SCT; CVP score of survivors was 9 (range 8-10) CVP in nonsurvivors 7 (range 4-9) p<0.004 Respondek et al. ISUOG Abstract Sept. 2005

Perinatal Cardiology Cardiology for the fetus, child, and mother Fetal therapy has the potential for 200% mortality Early intervention could change the natural history of disease Mother must be a willing participant

Group Perinatal Mortality CVP score Mortality* or Early Delivery** 1 (CHD)20%<7*87.5% vs. 15.2% 2 (Hydrops)60%<7*73.5% vs. 26.5% 3 (IUGR)11%<6100% 4 (AVB) *82%, **26% <7 *100%, **100% 5 (Digoxin)32%<5100% Summary: CVPS Associated with Mortality

Group Component Markers P-Value 1 (CHD)Hydrops, Cardiomegaly < (Hydrops)Abn venous D 3 (IUGR)Abn venous D Abn function Cardiomegaly < (LAI-AVB)Hydrops Cardiomegaly < (Digoxin)Abn DV D Hydrops Component Markers Associated with Mortality

Future Research Disease – specific CVP Score Comparison with Biophysical Profile Score First Trimester CVP Score Mouse embryo CVP Score

Advances in Perinatal Cardiology 10th Course Advances in Perinatal Cardiology 10th Fun in the Sun Course Focus: Fetal Treatment See “Conferences ” Oct.23-26, 2014 St. Petersburg, FL